CTOs on the Move

HealthLynked

www.healthlynked.com

 
HealthLynked (OTCQB: HLYK) provides a solution for both patient members and providers to improve healthcare by efficiently exchanging medical information. The HealthLynked Network is a cloud-based platform that allows members to connect with their healthcare providers and take control of their medical data. Members can enter their medications, allergies, past surgeries, and personal health records into one convenient online and secure location. Participating healthcare providers can connect with their current and future patients through the HealthLynked Network. Providers also get the benefit of using HealthLynked marketing tools to communicate with their active and inactive patients to improve patient retention, access ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Aaron Diamond AIDS Research Center

Aaron Diamond AIDS Research Center is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Beiersdorf, Inc.

Beiersdorf, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Wilton, CT. To find more information about Beiersdorf, Inc., please visit www.bdfusa.com

ROWI

ROWI Teen is a mental health treatment center for teens and adolescents, specializing in mental health issues like depression, anxiety, OCD, and ASD.

Hyperion Technology Group

Hyperion Technology Group is a defense and space company based in Madrid, Spain.

Orbus Therapeutics

Orbus Therapeutics is dedicated to developing products that treat rare diseases for which there are few, if any, effective therapies. The company’s product candidate in development is eflornithine in an oral solution. Eflornithine is a novel cytostatic agent, which Orbus Therapeutics is developing for the treatment of patients with anaplastic glioma (AG), or Grade 3 glioma, a rare form of central nervous system cancer. Eflornithine irreversibly inhibits ornithine decarboxylase (ODC), a key enzyme in mammalian polyamine biosynthesis that is up-regulated in various types of cancer. Orbus Therapeutics intends to develop and commercialize eflornithine in North America.